Medications
FDA approves Winrevair for pulmonary arterial hypertension in adults
The U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.
58 minutes ago
0
0